- Report ID: BMRC 264 | Number of pages: 192 | Publish Date: Jan 2020
Status: Published | Category: Medical Devices and Consumables | Delivery Timeline: 48 hrs
A recent report on Cardiac Biomarkers Market provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and latest growth trends accepted by key players that form a part of the competitive spectrum of this business.
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.
There is a high demand for cardiac biomarkers due to their proficiency and the ability to provide accurate results. The number of clinical trials conducted for cardiac biomarkers is steadily increasing since manufactures, universities, and research institutes are focused on improving the efficiency and efficacy of the biomarkers. Cardiac biomarker manufacturers are increasingly focusing on R&D to perform several clinical trials to prove the effectiveness of the products and increase their consumer base. According to our industry research and analysis, the increase in number of clinical trials will be one of the key trends that will gain traction in the cardiac biomarkers market during the next few years.
North America leads the global market, owing to the high demand for cardiac testing, high CVD prevalence rate and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to the modernization, increasing disposable incomes and rising affordability for the advanced cardiac treatments.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiac Biomarkers. This report studies the global market size of Cardiac Biomarkers, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiac Biomarkers production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott
Alere
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED
Market Segment by Product Type
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
Market Segment by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
In this study, the years considered to estimate the market size of Cardiac Biomarkers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Qualitative Analysis covers:
Quantitative Analysis covers:
Interested in this report?
Table of Content
Chapter 1 Global Cardiac Biomarkers Market: Summary and Quantitative Analysis
1.1 Report Description
1.2 Global Cardiac Biomarkers Market Revenue Overview
1.3 Global Cardiac Biomarkers Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025
Chapter 2 Global Cardiac Biomarkers Market: Overview and Qualitative Analysis
2.1 Executive Summary
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Cardiac Biomarkers Market: SWOT Analysis
2.7 Global Cardiac Biomarkers Market: PEST Analysis
2.7 Global Cardiac Biomarkers Market: Porter’s Five Forces Analysis
2.8 Global Cardiac Biomarkers Market: Attractiveness Analysis
2.8.1 Global Cardiac Biomarkers Market: Attractiveness Analysis by Type
2.8.2 Global Cardiac Biomarkers Market: Attractiveness Analysis by Grade
2.8.3 Global Cardiac Biomarkers Market: Attractiveness Analysis by Regional
Chapter 3 Competitive Analysis
3.1 Global Cardiac Biomarkers Market
3.1.1 Global Cardiac Biomarkers market Revenue (USD Billion), By Players 2018
3.1.2 Global Cardiac Biomarkers Market Revenue Share (%), By Players 2018
Chapter 5 Global Cardiac Biomarkers Market: By Product Type
5.1 Global Cardiac Biomarkers Market Share (%), By Product Type, 2018
5.2 Global Cardiac Biomarkers Market Revenue (USD Billion), By Product Type, 2015 – 2025
5.3 Global Cardiac Biomarkers Market Revenue (USD Billion), By Retro,2015-2025
5.4 Global Cardiac Biomarkers Market Revenue (USD Billion), By Standing/Self-Balancing, 2015-2025
5.4 Global Cardiac Biomarkers Market Revenue (USD Billion), By Folding, 2015-2025
5.5 Global Cardiac Biomarkers Market Revenue Share (%), By Product Type, 2015 – 2025
5.6 Global Cardiac Biomarkers Market Revenue Market Share (%), By Product Type, 2015-2025
Chapter 6 Global Cardiac Biomarkers Market: By Product Type
6.1 Global Cardiac Biomarkers Market Share (%), By Product Type, 2018
6.2 Global Cardiac Biomarkers Market Revenue (USD Billion), By Type, 2015 – 2025
Chapter 7 North America Cardiac Biomarkers Market Analysis
7.1 North America Market Snapshot
7.1.1 North America Cardiac Biomarkers Market Revenue and Growth Rate (%), 2015-2025.
7.1.2 North America Cardiac Biomarkers Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
7.1.3 North America Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.5 North America Cardiac Biomarkers Revenue (USD Billion) Overview, By Product Type, 2015-2025
7.1.6 North America Cardiac Biomarkers Revenue (USD Billion) Overview, By Product Type , 2015-2025
Chapter 8 Europe Cardiac Biomarkers Market Analysis
8.1 Europe Market Snapshot
8.1.1 Europe Cardiac Biomarkers Market Revenue and Growth Rate (%), 2015-2025.
8.1.2 Europe Cardiac Biomarkers Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
8.1.3 Europe Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
8.1.5 Europe Cardiac Biomarkers Revenue (USD Billion) Overview, By Product Type, 2015-2025
8.1.6 Europe Cardiac Biomarkers Revenue (USD Billion) Overview, By Type, 2015-2025
Chapter 9 Asia Pacific Cardiac Biomarkers Market Analysis
9.1 Asia Pacific Market Snapshot
9.1.1 Asia Pacific Cardiac Biomarkers Market Revenue and Growth Rate (%), 2015-2025.
9.1.2 Asia Pacific Cardiac Biomarkers Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
9.1.3 Asia Pacific Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
9.1.5 Asia Pacific Cardiac Biomarkers Revenue (USD Billion) Overview, By Product Type, 2015-2025
9.1.6 Asia Pacific Cardiac Biomarkers Revenue (USD Billion) Overview, By Type, 2015-2025
Chapter 10 Latin America Cardiac Biomarkers Market Analysis
10.1 Latin America Market Snapshot
10.1.1 Latin America Cardiac Biomarkers Market Revenue and Growth Rate (%), 2015-2025.
10.1.2 Latin America Cardiac Biomarkers Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
10.1.3 Latin America Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
10.1.5 Latin America Cardiac Biomarkers Revenue (USD Billion) Overview, By Product Type, 2015-2025
10.1.6 Latin America Cardiac Biomarkers Revenue (USD Billion) Overview, By Type, 2015-2025
Chapter 11 Middle East & Africa Cardiac Biomarkers Market Analysis
11.1 Middle East & Africa Market Snapshot
11.1.1 Middle East & Africa Cardiac Biomarkers Market Revenue and Growth Rate (%), 2015-2025.
11.1.2 Middle East & Africa Cardiac Biomarkers Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
11.1.3 Middle East & Africa Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
11.1.5 Middle East & Africa Cardiac Biomarkers Revenue (USD Billion) Overview, By Product Type, 2015-2025
11.1.6 Middle East & Africa Cardiac Biomarkers Revenue (USD Billion) Overview, By Type, 2015-2025
Chapter 12 Competitive Analysis
12.1 Company 1.
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 Company 1. Total Company Revenue 2015-2018
12.1.3 Company 1. Total Company Revenue, By Segment of Business 2015-2018
12.1.4 Company 1. Total Company Revenue, By Region 2015-2018
12.1.5 Company 1. Global Cardiac Biomarkers Product Category and Description
12.1.6 Company 1. Recent Activity 2015-2019
12.1.7 Main Business/Business Overview
12.1.8 Business Strategy
12.1.9 SWOT Analysis
12.2 Company 2.
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.2.2 Company 2. Total Company Revenue 2015-2018
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018
12.2.5 Company 2. Global Cardiac Biomarkers Product Category and Description
12.2.6 Company 2. Recent Activity 2015-2019
12.2.7 Main Business/Business Overview
12.2.8 Business Strategy
12.2.9 SWOT Analysis
12.3 Company 3
12.3.1 Business Overview
12.3.2 Company 3Market Product Category and Description & Specification
12.3.3 Main Business/Business Overview
12.3.4 Business Strategy
12.3.5 SWOT Analysis
12.4 Company 4.
12.4.1 Business Overview
12.4.2 Company 4.Company Total Company Revenue 2015-2018
12.4.3 Company 4.Company Total Company Revenue, By Segment of Business 2015-2018
12.4.4 Company 4.Company Total Company Revenue, By Region of Business 2015-2018
12.4.5 Company 4.Company Product Category, Specification and Description
12.4.6 Company 4.Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.4.7 Company 4.Company Main Business/Business Overview
12.4.8 Business Strategy
12.4.9 SWOT Analysis
12.5 Company 5
12.5.1 Business Overview
12.5.2 Company 5 Company Net Sales 2015-2018
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018
12.5.4 Company 5 Company Net Sales, By Region 2015-2018
12.5.5 Company 5 Cardiac Biomarkers Market Product Category and Specification
12.5.6 Company 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.5.7 Company 5 Main Business/Business Overview
12.5.8 Business Strategy
12.5.9 SWOT Analysis
12.6 Company 6
12.6.1 Business Overview
12.6.2 Company 6 Cardiac Biomarkers Market Product Category and Specification
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.6.4 Company 6 Main Business/Business Overview
12.6.5 Business Strategy
12.6.6 SWOT Analysis
Chapter 13 Market Research Findings & Conclusion
Chapter 14 Research Methodology
14.1 Research Process
14.2 Primary Research
14.3 Secondary Research
14.4 Market Size Estimates
14.5 Forecast Model
14.7 Who is This Report For?
14.8 USP’s of Report
?
List of Figures
FIG. 1 Global Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025
FIG. 4 Global Cardiac Biomarkers Market: Attractiveness Analysis By Product Type
FIG. 5 Global Cardiac Biomarkers Market: Attractiveness Analysis By Type
FIG. 6 Global Cardiac Biomarkers Market: Attractiveness Analysis by Regional
FIG. 7 Global Cardiac Biomarkers Market
FIG. 8 Global Cardiac Biomarkers Market Share (%), By Product Type, 2018
FIG. 9 Global Cardiac Biomarkers Market Revenue (USD Billion), By Application, 2015-2025
FIG. 10 Global Cardiac Biomarkers Market Revenue (USD Billion), By End Use , 2015-2025
FIG. 10 Global Cardiac Biomarkers Market Revenue (USD Billion), By Type, 2015-2025
FIG. 11 Global Cardiac Biomarkers Market Revenue Market Share (%), By Product Type, 2015-2025
FIG. 20 North America Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 21 North America Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 22 Europe Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 23 Europe Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 24 Asia Pacific Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 25 Asia Pacific Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 26 Latin America Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 27 Latin America Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 28 Middle East & Africa Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 29 Middle East & Africa Cardiac Biomarkers Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 30 Company 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 31 Company 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 32 Company 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million)
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 119
FIG. 36 Company 3 Total Company Revenue 2015-2018 (USD Million)
FIG. 37 Company 3 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 38 Company 3 Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %)
FIG. 39 Company 4. Company Net Sales 2015-2018 (USD Million, R & D Expenses %)
FIG. 40 Company 4. Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 41 Company 4. Company Net Sales, by Region 2015-2018 (USD Million, AGR %)
FIG. 42 Company 5 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 43 Company 5 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 44 Primary Research
FIG. 45 Sources of Secondary Research
FIG. 46 Forecast Model
List of Tables
TABLE 1 Global Cardiac Biomarkers Market Overview
TABLE 2 Market Driver Impact Analysis
TABLE 3 Market Restraints Impact Analysis
TABLE 4 Global Cardiac Biomarkers market Revenue (USD Billion), By Players2018
TABLE 5 Global Cardiac Biomarkers market Revenue Market share (%), By Players- 2018
TABLE 6 Global Cardiac Biomarkers Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 7 Global Cardiac Biomarkers Market Revenue Share (%), By Product Type, 2015 - 2025
TABLE 8 Global Cardiac Biomarkers Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 9 Global Cardiac Biomarkers Market Revenue Share (%), By Product Type, 2015 - 2025
TABLE 10 Global Cardiac Biomarkers Market Revenue (USD Billion), 2015 - 2025
TABLE 11 Global Cardiac Biomarkers Market Revenue Share (%), By , 2015 - 2025
More …………...
Global Cardiac Biomarkers MarketSize, Share, Growth Trends, Competitive, Historical & Forecast Analysis, 2020-2025
